Ignite Creation Date:
2024-07-17 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06461468
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-17
First Post:
2024-06-04
Brief Title:
Hypertrophic Cardiomyopathy Federated Learning Implementation Platform
Sponsor:
American Heart Association
Organization:
American Heart Association
Study Overview
Official Title:
Detection of Hypertrophic Cardiomyopathy Using Electrocardiograms and Echocardiograms Through Federated Learning
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HCM FLIP
Brief Summary:
HCM FLIP study is a two-phase protocol focusing on the detection of Hypertrophic Cardiomyopathy using Electrocardiograms and Echocardiograms through Federated Learning
Detailed Description:
HCM FLIP Hypertrophic Cardiomyopathy Federated Learning Implementation Platform aim to build and test a models system impact to detect hypertrophic cardiomyopathy HCM by training a machine learning ML model with electrocardiograms ECGs and echocardiograms ECHOs Approximately 10-1000 HCM cases and 30-10000 agesex-matched controls per institution depending on size will be included in the study We hypothesize that a federated ML model will discriminate cases of HCM from those without HCM in a real-world setting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None